This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Congenital glaucoma
Q17_CONGEN_GLAUC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
43 |
4. Check minimum number of eventsNone |
43 |
5. Include endpointsNone |
43 |
6. Filter based on genotype QC (FinnGen only) |
43 |
Control definitions (FinnGen only)
- Control exclude
- Q17_CONGEN_MALFO_EYE_EAR_FACE_NECK
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF6v3
Similar endpoints
↥List of similar endpoints to
Congenital glaucoma
based on the number of shared cases.
Similar with more cases:
- Other congenital malformations of eye
- Congenital malformations of eye, ear, face and neck
- Congenital malformations, deformations and chromosomal abnormalities
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 427 | 189 | 235 |
| Only index persons | 351 | 158 | 193 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.01 | 0.01 | 0.01 |
| Only index persons | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | |||
| Whole population | 20.21 | 29.94 | 11.72 |
| Only index persons | 23.28 | 30.94 | 17.01 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 43 | 22 | 21 |
| Unadjusted period prevalence (%) | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | 44.94 | 43.80 | 46.13 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
No data
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3044889) 12 lead EKG panel
31
213
2.63
2.11
3.9
3.6
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
11
48
2.74
1.89
2.0
2.4
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
14
70
2.48
1.85
3.4
2.8
e6/l
0.1
0.9
—
9
45
(3007461) Platelets [#/volume] in Blood
43
382
+∞
1.84
21.9
22.4
e9/l
238.3
250.9
0.64
43
372
(3026361) Erythrocytes [#/volume] in Blood
43
382
+∞
1.84
21.9
22.4
e12/l
4.5
4.5
0.10
43
368
(3010813) Leukocytes [#/volume] in Blood
43
382
+∞
1.84
21.9
22.5
e9/l
6.5
6.8
0.28
43
369
(3024731) MCV [Entitic volume]
43
382
+∞
1.84
21.9
22.3
fl
88.6
89.4
0.38
43
374
(3000963) Hemoglobin [Mass/volume] in Blood
43
382
+∞
1.84
21.9
22.5
g/l
131.0
133.3
0.47
43
374
(3035941) MCH [Entitic mass]
43
382
+∞
1.84
21.9
22.3
pg
29.4
29.8
0.66
43
374
(40758558) Short blood count panel - Blood
18
103
2.29
1.76
4.6
7.0
—
—
—
0
0
(3003338) MCHC [Mass/volume]
37
295
2.82
1.66
19.1
19.4
g/l
331.4
333.4
0.61
37
295
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
13
66
2.39
1.65
3.5
3.1
e6/l
7.1
2.4
—
8
41
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
21
137
2.04
1.43
5.8
3.5
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
18
115
1.97
1.27
5.8
3.0
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
16
100
1.96
1.18
2.3
2.6
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
22
154
1.88
1.16
8.5
9.7
mmol/l
1.2
1.2
0.54
22
146
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
35
293
2.04
1.08
13.7
13.8
ml/min/173m2
81.9
82.8
0.07
29
232
(3009542) Hematocrit [Volume Fraction] of Blood
38
329
2.33
1.07
16.8
16.8
%
37.6
39.4
0.62
31
250
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
7
35
2.19
1.05
3.0
3.7
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
19
131
1.81
1.02
5.9
6.5
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
14
88
1.88
1.00
3.8
3.3
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
31
250
1.86
0.97
7.0
7.8
u/l
87.3
92.3
0.17
31
238
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
12
73
1.89
0.94
2.8
1.7
mmol/l
1.2
1.3
0.35
12
59
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
17
117
1.75
0.90
5.0
3.8
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
17
118
1.73
0.87
2.1
1.8
pmol/l
77.2
91.8
—
10
57
(3023368) Bacteria identified in Blood by Culture
16
110
1.72
0.84
2.8
5.0
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
9
55
1.80
0.80
2.2
2.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
16
115
1.62
0.70
1.6
2.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
0
19
0.00
0.62
0.0
1.8
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
0
22
0.00
0.61
0.0
1.6
—
—
—
0
0
(3019225) pH of Specimen
0
23
0.00
0.60
0.0
8.9
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
6
36
1.77
0.59
1.0
1.2
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
15
112
1.52
0.54
4.1
3.2
mmol/l
2.4
2.4
0.62
15
97
(3013512) EKG study
12
87
1.53
0.49
1.4
5.1
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
27
231
1.45
0.48
5.5
4.6
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
8
56
1.52
0.46
1.8
1.8
nmol/l
1393.8
1200.0
—
8
46
(3006504) Eosinophils/100 leukocytes in Blood
21
174
1.40
0.43
6.5
6.5
%
3.8
3.0
0.92
21
163
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
0
16
0.00
0.42
0.0
1.3
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
21
175
1.39
0.42
7.8
6.4
%
53.6
54.4
0.07
21
166
(3019069) Monocytes/100 leukocytes in Blood
21
175
1.39
0.42
6.5
6.6
%
9.4
8.5
0.66
21
165
(3001122) Ferritin [Mass/volume] in Serum or Plasma
18
146
1.40
0.42
3.1
2.8
ug/l
138.0
90.7
0.43
18
138
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
0
17
0.00
0.41
0.0
1.3
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
0
17
0.00
0.41
0.0
1.3
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
0
17
0.00
0.41
0.0
1.3
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
5
76
0.61
0.40
1.4
3.7
umol/l
346.2
360.1
—
5
61
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
5
36
1.44
0.39
1.2
1.7
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
21
178
1.35
0.36
6.5
6.6
%
29.3
29.8
0.04
21
167
(1761868) Lipid panel - Serum or Plasma
8
107
0.69
0.34
3.6
2.8
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
7
51
1.44
0.34
1.4
1.2
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
12
94
1.38
0.32
3.6
4.8
ug/l
1.2
2.2
0.75
12
79
(3015736) pH of Urine
16
132
1.34
0.32
4.4
3.4
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
20
171
1.32
0.31
6.8
6.5
%
0.8
0.7
1.03
20
161
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
8
65
1.28
0.29
1.0
2.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
11
87
1.36
0.28
1.5
1.5
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
32
295
1.33
0.27
4.7
4.2
mmol/l
1.4
1.4
0.09
32
261
(36660697) Celiac disease serology panel - Serum
5
40
1.28
0.23
1.0
1.2
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
5
41
1.25
0.23
2.2
1.3
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
6
47
1.32
0.21
1.0
2.0
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
6
47
1.32
0.21
1.0
2.0
—
—
—
0
0
(44790048)
0
11
0.00
0.21
0.0
2.1
—
—
—
0
0
(44790047)
0
11
0.00
0.21
0.0
2.1
—
—
—
0
0
(44806118)
0
11
0.00
0.21
0.0
2.1
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
0
11
0.00
0.21
0.0
3.4
—
3.8
—
0
11
(3006184) Hemoglobin [Mass/volume] in Capillary blood
0
11
0.00
0.21
0.0
2.4
—
113.2
—
0
6
(44790049)
0
11
0.00
0.21
0.0
2.1
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
2.2
—
17.1
—
0
10
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.1
—
322.5
—
0
10
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
0
10
0.00
0.21
0.0
2.6
—
13.7
—
0
5
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.3
—
0.3
—
0
12
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
(40768793) Breast Pathology biopsy report
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3008898) HLA-B27 [Presence]
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
0
13
0.00
0.21
0.0
3.5
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.5
—
1.1
—
0
13
(46235355) HIV 1 and 2 tests - Meaningful Use set
7
60
1.20
0.19
2.3
1.5
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
7
60
1.20
0.19
2.1
1.8
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
7
61
1.18
0.19
5.4
10.2
mmol/l
0.7
0.8
—
7
56
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
5
67
0.71
0.18
1.8
1.7
pmol/l
433.8
494.6
—
5
58
(3021960) Folate [Moles/volume] in Serum or Plasma
8
69
1.20
0.18
1.5
1.4
nmol/l
24.4
21.4
—
8
54
(3032080) INR in Blood by Coagulation assay
15
131
1.22
0.17
10.5
8.2
inr
1.3
1.2
—
7
41
(40760892) CBC W Ordered Manual Differential panel - Blood
8
71
1.16
0.17
7.6
5.0
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
9
81
1.14
0.16
1.8
3.1
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
19
171
1.20
0.16
5.7
7.5
umol/l
25.1
19.7
0.16
19
165
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
32
304
1.21
0.13
5.3
4.6
mmol/l
2.6
2.7
0.31
32
271
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
27
286
0.85
0.13
5.4
5.7
mmol/mol
37.6
39.5
0.79
27
261
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
32
305
1.19
0.12
4.0
4.4
mu/l
1.7
2.0
0.97
32
271
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
5
44
1.15
0.10
1.2
1.4
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
5
47
1.07
0.10
9.6
13.8
mmol/l
25.2
24.7
—
5
47
(3003458) Phosphate [Moles/volume] in Serum or Plasma
7
63
1.13
0.09
12.7
9.0
mmol/l
1.0
1.2
—
7
57
(3041096) Erythrocytes [Presence] in Urine by Automated
9
85
1.07
0.07
6.2
3.2
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
12
109
1.14
0.07
1.9
3.1
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
24
251
0.90
0.06
3.8
3.9
pmol/l
14.7
14.7
0.03
24
229
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
14
134
1.07
0.01
3.1
3.7
ng/l
32.9
44.6
—
9
100
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
24
246
0.94
0.01
2.8
3.6
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
30
299
1.01
0.00
4.9
4.4
mmol/l
5.7
5.8
0.61
30
269
(3024561) Albumin [Mass/volume] in Serum or Plasma
15
151
0.99
0.00
6.3
5.0
g/l
37.4
35.9
0.39
15
142
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
10
96
1.05
0.00
3.7
2.6
u/l
71.2
55.9
—
10
90
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
29
286
1.04
0.00
4.0
3.8
mmol/l
1.1
1.2
0.39
29
251
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
14
142
0.98
0.00
4.9
4.5
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
0
6
0.00
0.00
0.0
1.3
—
88.7
—
0
6
(3027901) Hemoglobin [Mass/volume] in Arterial cord blood
0
6
0.00
0.00
0.0
1.0
—
168.3
—
0
6
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
175.0
—
0
5
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
0
7
0.00
0.00
0.0
3.3
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.1
—
3.9
—
0
9
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
154.2
—
0
5
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
0
5
0.00
0.00
0.0
6.8
—
78.2
—
0
5
(3004616) Nuclear Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(4094501)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.4
—
77.7
—
0
8
(3035933) Granulocytes/100 leukocytes in Blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4027681)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
5
52
0.96
0.00
2.2
1.3
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
4.0
—
2.7
—
0
6
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
11.8
—
0
5
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
2.0
—
14.4
—
0
6
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
8
88
0.89
0.00
1.8
2.0
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
5.3
—
7.2
—
0
6
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
0
9
0.00
0.00
0.0
12.4
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
4.2
—
148.4
—
0
5
Mortality – FinRegistry
↥Association
Association between endpoint Q17_CONGEN_GLAUC and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have Q17_CONGEN_GLAUC.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: Q17_CONGEN_GLAUC – Congenital glaucoma
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data